630 related articles for article (PubMed ID: 34267518)
1. Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death.
Jin F; Liu D; Xu X; Ji J; Du Y
Int J Nanomedicine; 2021; 16():4693-4712. PubMed ID: 34267518
[TBL] [Abstract][Full Text] [Related]
2. Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy.
Gao J; Wang WQ; Pei Q; Lord MS; Yu HJ
Acta Pharmacol Sin; 2020 Jul; 41(7):986-994. PubMed ID: 32317755
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy.
Ji B; Wei M; Yang B
Theranostics; 2022; 12(1):434-458. PubMed ID: 34987658
[TBL] [Abstract][Full Text] [Related]
4. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future.
Alzeibak R; Mishchenko TA; Shilyagina NY; Balalaeva IV; Vedunova MV; Krysko DV
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33431631
[TBL] [Abstract][Full Text] [Related]
5. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy.
Zhang S; Wang J; Kong Z; Sun X; He Z; Sun B; Luo C; Sun J
Biomaterials; 2022 Mar; 282():121433. PubMed ID: 35202933
[TBL] [Abstract][Full Text] [Related]
6. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
7. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X
ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023
[TBL] [Abstract][Full Text] [Related]
8. Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency.
Li Z; Lai X; Fu S; Ren L; Cai H; Zhang H; Gu Z; Ma X; Luo K
Adv Sci (Weinh); 2022 Aug; 9(22):e2201734. PubMed ID: 35652198
[TBL] [Abstract][Full Text] [Related]
9. 5-ALA mediated photodynamic therapy with combined treatment improves anti-tumor efficacy of immunotherapy through boosting immunogenic cell death.
Sun Z; Zhao M; Wang W; Hong L; Wu Z; Luo G; Lu S; Tang Y; Li J; Wang J; Zhang Y; Zhang L
Cancer Lett; 2023 Feb; 554():216032. PubMed ID: 36493899
[TBL] [Abstract][Full Text] [Related]
10. Light-triggered photodynamic nanomedicines for overcoming localized therapeutic efficacy in cancer treatment.
Choi J; Sun IC; Sook Hwang H; Yeol Yoon H; Kim K
Adv Drug Deliv Rev; 2022 Jul; 186():114344. PubMed ID: 35580813
[TBL] [Abstract][Full Text] [Related]
11. Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor.
Wei X; Song M; Jiang G; Liang M; Chen C; Yang Z; Zou L
Theranostics; 2022; 12(12):5272-5298. PubMed ID: 35910806
[TBL] [Abstract][Full Text] [Related]
12. Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better.
Thiruppathi J; Vijayan V; Park IK; Lee SE; Rhee JH
Front Immunol; 2024; 15():1375767. PubMed ID: 38646546
[TBL] [Abstract][Full Text] [Related]
13. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y
Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy.
Demuynck R; Engelen Y; Skirtach AG; De Smedt SC; Lentacker I; Krysko DV
Trends Cancer; 2024 Jun; 10(6):486-489. PubMed ID: 38553361
[TBL] [Abstract][Full Text] [Related]
15. Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death.
Turubanova VD; Mishchenko TA; Balalaeva IV; Efimova I; Peskova NN; Klapshina LG; Lermontova SA; Bachert C; Krysko O; Vedunova MV; Krysko DV
Sci Rep; 2021 Mar; 11(1):7205. PubMed ID: 33785775
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy.
Duan X; Chan C; Lin W
Angew Chem Int Ed Engl; 2019 Jan; 58(3):670-680. PubMed ID: 30016571
[TBL] [Abstract][Full Text] [Related]
17. Nanoplatform-enhanced photodynamic therapy for the induction of immunogenic cell death.
Liu X; Lu Y; Li X; Luo L; You J
J Control Release; 2024 Jan; 365():1058-1073. PubMed ID: 38056695
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of Bee Venom Melittin and a Photosensitizer with an Organic-Inorganic Hybrid Nanocarrier for Photodynamic Therapy and Immunotherapy.
Liu H; Hu Y; Sun Y; Wan C; Zhang Z; Dai X; Lin Z; He Q; Yang Z; Huang P; Xiong Y; Cao J; Chen X; Chen Q; Lovell JF; Xu Z; Jin H; Yang K
ACS Nano; 2019 Nov; 13(11):12638-12652. PubMed ID: 31625721
[TBL] [Abstract][Full Text] [Related]
19. Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy.
Song H; Cai Z; Li J; Xiao H; Qi R; Zheng M
J Nanobiotechnology; 2022 Jul; 20(1):329. PubMed ID: 35842642
[TBL] [Abstract][Full Text] [Related]
20. Gold standard assessment of immunogenic cell death induced by photodynamic therapy: From in vitro to tumor mouse models and anti-cancer vaccination strategies.
Mishchenko TA; Balalaeva IV; Turubanova VD; Saviuk MO; Shilyagina NY; Krysko O; Vedunova MV; Krysko DV
Methods Cell Biol; 2024; 183():203-264. PubMed ID: 38548413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
